Associated Papers
Molecular Analysis of Genes CEBPA, NPM1, IDH1, and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients.
Bashir K et al.
Molecular Carcinogenesis, 2025
Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study.
Miyashita N et al.
International Journal of Hematology, 2023
Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity.
Pellegrino E et al.
Bioengineering (basel, Switzerland), 2023
37508780 (PubMed )
Supplement: bioengineering-10-00753-s001.zip › bioengineering-2428084-supplementary.xls › run24012023b_all
Germline mutations among Polish patients with acute myeloid leukemia.
Bąk A et al.
Hereditary Cancer in Clinical Practice, 2021
Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.
Smetana J et al.
Molecular Cytogenetics, 2018
29375670 (PubMed )
Supplement: 13039_2018_357_MOESM2_ESM.xlsx › variants
The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.
Konopka B et al.
Oncotarget, 2016
A clinical grade sequencing-based assay for CEBPA mutation testing: report of a large series of myeloid neoplasms.
Behdad A et al.
The Journal of Molecular Diagnostics : Jmd, 2015
Characterization of CEBPA Mutations and Polymorphisms and their Prognostic Relevance in De Novo Acute Myeloid Leukemia Patients.
Sarojam S et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2015
Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.
Kim S et al.
Annals of Laboratory Medicine, 2012
CCAAT/enhancer-binding protein alpha (CEBPA) polymorphisms and mutations in healthy individuals and in patients with peripheral artery disease, ischaemic heart disease and hyperlipidaemia.
Fuchs O et al.
Folia Biologica, 2010
Molecular study of CEBPA in familial hematological malignancies.
El Abed R et al.
Familial Cancer, 2009
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
Fuchs O et al.
Blood Cells, Molecules & Diseases, 0
Select a paper to view details